Peter Vozzo | IR |
Jerry Jabbour | CEO |
Terri Matkovits | Chief Development Officer |
Michael Okunewitch | Maxim Group |
Gregg Gilbert | Truist |
Welcome to the Matinas BioPharma Second Quarter 2020 Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded. I would now like to turn the conference over to Peter Vozzo, Investor Relations representative from Matinas BioPharma.